Neuroprotective effect of berberine against environmental heavy metals-induced neurotoxicity and Alzheimer's-like disease in rats

Abd El-Wahab, 2013, In vitro biological assessment of berberis vulgaris and its active constituent, berberine: antioxidants, anti-acetylcholinesterase, anti-diabetic and anticancer effects, BMC Complement. Altern. Med., 13, 218, 10.1186/1472-6882-13-218 Adedara, 2017, Neuroprotective influence of taurine on fluoride-induced biochemical and behavioral deficits in rats, Chem. Biol. Interact., 261, 1, 10.1016/j.cbi.2016.11.011 Ahmed, 2015, Berberine and neurodegeneration: a review of literature, Pharmacol. Rep., 67, 970, 10.1016/j.pharep.2015.03.002 Bate, 2010, Amyloid-β(1-40) inhibits amyloid-β(1-42) induced activation of cytoplasmic phospholipase A2 and synapse degeneration, JAD, 21, 985, 10.3233/JAD-2010-100528 Bautista-aguilera, 2014, Multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of alzheimer’s disease: design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybrids, Drug Des. Devel Ther., 8, 1893 Blaylock, 2004, Excitoxicity: a possible central mechanism in fluoride neurotoxicity, Fluoride, 37, 301 Bronzuoli, 2016, Targeting neuroinflammation in Alzheimer's disease, J. Inflamm. Res., 9, 199, 10.2147/JIR.S86958 Brown, 2005, Neurodegenerative diseases: an overview of environmental risk factors, Environ. Health Perspect., 113, 1250, 10.1289/ehp.7567 Buchhave, 2010, Soluble TNF receptors are associated with Aβ metabolism and conversion to dementia in subjects with mild cognitive impairment, Neurobiol. Aging, 31, 1877, 10.1016/j.neurobiolaging.2008.10.012 Cai, 2011, Oxidative stress and β-amyloid protein in Alzheimer’s disease, Neuromol Med., 13, 223, 10.1007/s12017-011-8155-9 Cai, 2016, Role of berberine in Alzheimer’s, Neuropsychiatr. Dis. Trea, 12, 2509, 10.2147/NDT.S114846 Cao, 2017, Hypericum perforatum extract attenuates behavioral, biochemical, and neurochemical abnormalities in Aluminum chloride-induced Alzheimer's disease rats, Biomed. Pharmacother., 91, 931, 10.1016/j.biopha.2017.05.022 Cavanagh, 2016, Inhibiting tumor necrosis factor-α before amyloidosis prevents synaptic deficits in an Alzheimer's disease model, Neurobiol. Aging, 47, 41, 10.1016/j.neurobiolaging.2016.07.009 Chen, 2008, Cadmium activates the mitogen activated protein kinase (MAPK) pathway via induction of reactive oxygen species and inhibition of protein phosphatases 2A and 5, Free Radic. Biol. Med., 45, 1035, 10.1016/j.freeradbiomed.2008.07.011 Chen, 2011, Bioavailability study of berberine and the enhancing effects of TPGS on intestinal absorption in rats, AAPS Pharm. Sci. Tech., 12, 705, 10.1208/s12249-011-9632-z Correia, 2012, Insulin signaling, glucose metabolism and mitochondria: major players in Alzheimer's disease and diabetes interrelation, Brain Res., 1441, 64, 10.1016/j.brainres.2011.12.063 Dá Mesquita, 2016, Insights on the pathophysiology of Alzheimer's disease: the crosstalk between amyloid pathology, neuroinflammation and the peripheral immune system, Neurosci. Biobehav Rev., 68, 547, 10.1016/j.neubiorev.2016.06.014 De Felice, 2008, Alzheimer's disease-type neuronal tau hyperphosphorylation induced by Aβ oligomers, Neurobiol. Aging, 29, 1334, 10.1016/j.neurobiolaging.2007.02.029 Drury, 1980, 188 Duan, 2015, Silibinin inhibits acetylcholinesterase activity and amyloid β peptide aggregation: a dual-target drug for the treatment of Alzheimer’s disease, Neurobiol. Aging, 36, 1792, 10.1016/j.neurobiolaging.2015.02.002 Ellman, 1961, A new and rapid colorimetric determination of acetylcholinesterase activity, Biochem Pharmacol., 7, 88, 10.1016/0006-2952(61)90145-9 Esterbauer, 1990, Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal, Methods Enzymol., 186, 407, 10.1016/0076-6879(90)86134-H Fang, 2010, RAGE-dependent signaling in microglia contributes to neuroinflammation, A beta accumulation, and impaired learning/memory in a mouse model of Alzheimer’s disease, FASEB J., 24, 1043, 10.1096/fj.09-139634 Feng, 2012, Berberine ameliorates COX-2 expression in rat small intestinal mucosa partially through PPARγ pathway during acute endotoxemia, Int. Immunopharmacol., 12, 182, 10.1016/j.intimp.2011.11.009 García-Ayllón, 2011, Revisiting the role of acetylcholinesterase in Alzheimer’s disease: cross-talk with P-tau and β-amyloid, Front. Mol. Neurosci., 4, 1, 10.3389/fnmol.2011.00022 Ghareeb, 2010, Efficacy of natural extracts of Ginkgo biloba and berberry and a synthetic derivative of genistein (ipriflavone), as acetylcholinesterase inhibitors, comparative study with Aricept® effect, J. Biochem Biotechnol., 1, 5 Gonçalves, 2012, Behavior and brain enzymatic changes after long-term intoxication with cadmium salt or contaminated potatoes, Food Chem. Toxicol., 50, 3709, 10.1016/j.fct.2012.07.016 Habig, 1974, Glutathione-S- transferase. The first enzymatic step in mercapturic acid formation, J. Biol. Chem., 249, 7130, 10.1016/S0021-9258(19)42083-8 Habtemariam, 2016, Berberine and inflammatory bowel disease: a concise review, Pharmacol. Res., 113, 592, 10.1016/j.phrs.2016.09.041 Han, 2016, Amyloid β-interacting partners in Alzheimer's disease: from accomplices to possible therapeutic targets, Prog. Neurobiol., 137, 17, 10.1016/j.pneurobio.2015.12.004 He, 2017, Berberine attenuates cognitive impairment and ameliorates tau hyperphosphorylation by limiting the self-perpetuating pathogenic cycle between NF-kB signaling, oxidative stress and neuro-inflammation, Pharmacol. Rep., 69, 1341, 10.1016/j.pharep.2017.06.006 Hong-Qi, 2012, Current advances in the treatment of Alzheimer's disease: focused on considerations targeting Aβ and tau, Transl. Neurodegener., 1, 21, 10.1186/2047-9158-1-21 Honjo, 2012, Alzheimer’s Disease, cerebrovascular disease, and the β−amyloid cascade, Can. J. Neurol. Sci., 39, 712, 10.1017/S0317167100015547 Huang, 2017, Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of β-amyloid in APP/tau/PS1 mouse model of Alzheimer's disease, Exp. Gerontol., 91, 25, 10.1016/j.exger.2017.02.004 Hung, 2016, Mutated tau, amyloid and neuroinflammation in Alzheimer disease—a brief review, Prog. Histochem Cytochem, 51, 1, 10.1016/j.proghi.2016.01.001 Ji, 2011, Berberine: a potential multipotent natural product to combat Alzheimer’s disease, Molecules, 16, 6732, 10.3390/molecules16086732 Ji, 2012, Molecular basis of inhibitory activities of berberine against pathogenic enzymes in Alzheimer's disease, Sci. World J., 2012, 823201, 10.1100/2012/823201 Jin, 2015, CART treatment improves memory and synaptic structure in APP/PS1 mice, Sci. Rep., 5, 10224, 10.1038/srep10224 Jollow, 1974, Bromobenzene induced liver necrosis: protective role of glutathione and evidence for 3, 4-bromobenzenoxide as the hepatotoxic intermediate, Pharmacology, 11, 151, 10.1159/000136485 Kalra, 2016, Modulation of LOX and COX pathways via inhibition of amyloidogenesis contributes to mitoprotection against β-amyloid oligomer-induced toxicity in an animal model of Alzheimer's disease in rats, Pharmacol. Biochem Behav., 146–147, 1, 10.1016/j.pbb.2016.04.002 Kheir, 2010, Acute toxicity of berberine and its correlation with the blood concentration in mice, Food Chem. Toxicol., 48, 1105, 10.1016/j.fct.2010.01.033 Kim, 2007, Aβ40 inhibits amyloid deposition In vivo, J. Neurosci., 27, 627, 10.1523/JNEUROSCI.4849-06.2007 Kulkarni, 2010, Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders, Phytother. Res., 243, 317, 10.1002/ptr.2968 Kumar, 2011, Galantamine potentiates the protective effect of rofecoxib and caffeic acid against intrahippocampal Kainic acid-induced cognitive dysfunction in rat, Brain. Res. Bull., 85, 158, 10.1016/j.brainresbull.2011.03.010 Kumar, 2015, Current knowledge and pharmacological profile of berberine: an update, Eur. J. Pharmacol., 761, 288, 10.1016/j.ejphar.2015.05.068 Li, 2014, Antioxidant and anti-inflammatory activities of berberine in the treatment of diabetes Mellitus, Evid. Base. Compl. Altern. Med. Liu, 2016, Research progress on berberine with a special focus on its oral bioavailability, Fitoterapia, 109, 274, 10.1016/j.fitote.2016.02.001 Liu, 2016, Design, synthesis and evaluation of novel dual monoamine-cholinesterase inhibitors as potential treatment for Alzheimer's disease, Neuropharmacology, 109, 376, 10.1016/j.neuropharm.2016.06.013 Lukiw, 2005, Nanomolar aluminum induces pro-inflammatory and pro-apoptotic gene expression in human brain cells in primary culture, J. Inorg. Biochem, 99, 1895, 10.1016/j.jinorgbio.2005.04.021 Marklund, 1974, Involvement of the superoxide anion radical in the autooxidation of pyrogallol and a convenient assay for superoxide dismutase, Eur. J. Biochem, 74, 469, 10.1111/j.1432-1033.1974.tb03714.x Murakami, 2011, SOD1 (copper/zinc superoxide dismutase) deficiency drives amyloid β protein oligomerization and memory loss in mouse model of Alzheimer disease, J. Biol. Chem., 286, 44557, 10.1074/jbc.M111.279208 Nalivaeva, 2016, AChE and the amyloid precursor protein (APP) - cross-talk in Alzheimer's disease, Chem. Biol. Interact., 259, 301, 10.1016/j.cbi.2016.04.009 Nallagouni, 2017, Aluminium and fluoride impacts cortex, hippocampus and dentate gyrus structure in rats: protective effect of resveratrol, IJABPT, 8, 89 Ng, 2015, Plant alkaloids as drug leads for Alzheimer's disease, Neurochem Int., 89, 260, 10.1016/j.neuint.2015.07.018 Oktem, 2012, Resveratrol Attenuates doxorubicin-induced cellular damage by modulating nitric oxide and apoptosis, Exp. Toxicol. Pathol., 64, 471, 10.1016/j.etp.2010.11.001 Paglia, 1967, Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase, J. Lab. Med., 70, 158 Patil, 2015, Protective effect of berberine, an isoquinoline alkaloid ameliorates ethanol-induced oxidative stress and memory dysfunction in rats, Pharmacol. Biochem Behav., 136, 13, 10.1016/j.pbb.2015.07.001 Pogue, 2016, Aluminum, the genetic apparatus of the human CNS and Alzheimer's disease (AD), Morphologie, 100, 56, 10.1016/j.morpho.2016.01.001 Procaccini, 2016, Role of metabolism in neurodegenerative disorders, Metabolism, 65, 1376, 10.1016/j.metabol.2016.05.018 Reid, 2015, Butyrylcholinesterase-knockout reduces brain deposition of fibrillar β-amyloid in an Alzheimer mouse model, Neuroscience, 298, 424, 10.1016/j.neuroscience.2015.04.039 Sandler, 1981, Human platelet monoamine oxidase activity in health and disease: a review, J. Clin. Pathol., 34, 292, 10.1136/jcp.34.3.292 Sarkar, 2014, Ameliorative effects of oleanolic acid on fluoride induced metabolic and oxidative dysfunctions in rat brain: experimental and biochemical studies, Food Chem. Toxicol., 66, 224, 10.1016/j.fct.2014.01.020 Saxena, 2008, Effect of donepezil and tacrine on oxidative stress in intracerebral streptozotocin-induced model of dementia in mice, Eur. J. Pharmacol., 581, 283, 10.1016/j.ejphar.2007.12.009 Simões Pires, 2014, Berberine was neuroprotective against an in vitro model of brain ischemia: survival and apoptosis pathways involved, Brain Res., 1557, 26, 10.1016/j.brainres.2014.02.021 Simpson, 2010, Population variation in oxidative stress and astrocyte DNA damage in relation to Alzheimer-type pathology in the ageing brain, Neuropathol. Appl. Neurobiol., 36, 25, 10.1111/j.1365-2990.2009.01030.x Singh, 2015, Neuroprotective effect of Allium cepa L. in aluminium chloride induced neurotoxicity, Neurotoxicology, 49, 1, 10.1016/j.neuro.2015.04.007 Sosroseno, 2008, The role of nitric oxide on the proliferation of a human osteoblast cell line stimulated with hydroxyapatite, J. Oral Implantol., 34, 196, 10.1563/0.910.1 Spangenberg, 2016, Inflammation in Alzheimer’s disease: lessons learned from microglia-depletion models, Brain Behav. Immun., 61, 1, 10.1016/j.bbi.2016.07.003 Su, 2016, Reprint of: microglial toll-like receptors and Alzheimer’s disease, Brain Behav. Immun., 55, 166, 10.1016/j.bbi.2016.05.016 Tan, 2014, Biomarkers for preclinical Alzheimer’s disease, J. Alzheimers Dis., 42, 1051, 10.3233/JAD-140843 MOE (The Molecular Operating Environment), 2008. Chemical Computing Group Inc. Available from: http://www.chemcomp.com. Thippeswamy, 2013, Evaluation of Bacopa monniera for its synergistic activity with rivastigmine in reversing aluminum-induced memory loss and learning deficit in rats, J. Acupunct. Meridian Stud., 6, 208, 10.1016/j.jams.2013.02.004 Wang, 2013, Cadmium and its neurotoxic effects, Oxidative Med. Cell. Longev., 10.1155/2013/898034 Wang, 2016, Alpha-tocopherol quinine ameliorates spatial memory deficits by reducing beta-amyloid oligomers, neuroinflammation and oxidative stress in transgenic mice with Alzheimer's disease, Behav. Brain Res., 296, 109, 10.1016/j.bbr.2015.09.003 Wojtunik-Kulesza, 2016, The influence of common free radicals and antioxidants on development of Alzheimer’s Disease, Biomed. Pharmacother., 78, 39, 10.1016/j.biopha.2015.12.024 Xie, 2015, Multi-target tacrine-coumarin hybrids: cholinesterase and monoamine oxidase B inhibition properties against Alzheimer's disease, Eur. J. Med. Chem., 95, 153, 10.1016/j.ejmech.2015.03.040 Xie, 2015, Synthesis and evaluation of selegiline derivatives as monoamine oxidase inhibitor, antioxidant and metal chelator against Alzheimer’s disease, Bioorg Med. Chem., 23, 3722, 10.1016/j.bmc.2015.04.009 Yu, 2013, Berberine protects human renal proximal tubular cells from hypoxia/reoxygenation injury via inhibiting endoplasmic reticulum and mitochondrial stress pathways, J. Transl. Med., 11, 24, 10.1186/1479-5876-11-24 Zhang, 2016, Berberine alleviates postoperative cognitive dysfunction by suppressing neuroinflammation in aged mice, Int. Immunopharmacol., 38, 426, 10.1016/j.intimp.2016.06.031 Zhao, 2013, Oxidative stress and the pathogenesis of Alzheimer’s disease, Oxid. Med. Cell Longev., 10.1155/2013/316523